Ticker Scorecard - SAGE Basics Company: Sage Therapeutics, Inc. IPO Date: July 18, 2014 Sector: Healthcare Industry: Biotech Market Cap: $449.43M Activated in VL: True Average Daily Range Avg Daily Range: $1.58 | 2.56% Avg Daily Range (30 D): $0.10 | 1.44% Avg Daily Range (90 D): $0.17 | 2.79% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 2.15M Avg Daily Volume (90 D): 1.25M Trade Size Avg Trade Size (Sh.): 76 Avg Trade Size (Sh.) (30 D): 140 Avg Trade Size (Sh.) (90 D): 111 Institutional Trades Total Inst.Trades: 5,192 Avg Inst. Trade: $2.71M Avg Inst. Trade (30 D): $1.85M Avg Inst. Trade (90 D): $1.86M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.76M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 84.64K     News Jan 31, 2025 @ 7:20 PM Deal Dispatch: Sage And Silvus Are Up For Sale, Mr... Source: Anthony Noto Jan 24, 2025 @ 6:38 PM Kuehn Law Encourages Investors of Sage Therapeutic... Source: N/A Jan 13, 2025 @ 7:06 PM Biogen Bid For Sage Therapeutics Could Strengthen ... Source: Vandana Singh Oct 28, 2024 @ 8:00 PM SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Gross... Source: Bronstein, Gewirtz & Grossman, Llc Oct 28, 2024 @ 2:10 PM Sage Therapeutics Inc Sued for Securities Law Viol... Source: Prnewswire Financials   TTM Q4 2024 FY 2024 Basic EPS $-6.59 $-1.56 $-6.59 Diluted EPS $-6.59 $-1.56 $-6.59 Revenue $ 41.24M $ 12.82M $ 41.24M Gross Profit $ $ $ Net Income / Loss $ -400.67M $ -95.78M $ -400.67M Operating Income / Loss $ -432.37M $ -102.19M $ -432.37M Cost of Revenue $ $ $ Net Cash Flow $ 10.15M $ -19.99M $ 10.15M PE Ratio